Gallbladder metastasis of renal cell carcinoma presenting as a hypervascular polypoid lesion: case report of two cases with immunohistochemical analysis.

Gallbladder metastasis Polypoid lesion of the gallbladder Renal cell carcinoma

Journal

Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125

Informations de publication

Date de publication:
28 Apr 2020
Historique:
received: 19 08 2019
accepted: 05 03 2020
entrez: 30 4 2020
pubmed: 30 4 2020
medline: 30 4 2020
Statut: epublish

Résumé

Metastasis of renal cell carcinoma (RCC) to the gallbladder is rare, and its clinicopathological feature remains poorly understood. We here present two cases of gallbladder metastasis from RCC presenting as a hypervascular polypoid lesion. The first case was a 73-year-old man who had undergone right nephrectomy for clear cell RCC. Imaging studies detected a hypervascular polypoid lesion in the gallbladder 6 years after nephrectomy. Laparoscopic cholecystectomy was done. The pathological findings of the polypoid lesion showed proliferation of clear cells in the submucosal layer. Immunohistochemically, the tumor was positive for carbonic anhydrase 9 (CA9) but negative for cytokeratin 7 (CK7), suggestive of metastatic RCC. The second case was a 43-year-old man who had undergone right nephrectomy for clear cell RCC. Imaging studies revealed a hypervascular polypoid lesion of 20 mm in diameter in the gallbladder 1 year after nephrectomy. The patient underwent expanded cholecystectomy and extra-hepatic bile duct resection with lymphadenectomy. Microscopically, the polypoid lesion of the gallbladder was composed of clear cells in the submucosal layer. Immunohistochemical analysis showed positive staining for epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA) but negative staining for CK7, leading to the diagnosis of metastatic RCC. Gallbladder metastasis from RCC is rare but should be considered when a hypervascular polypoid lesion in the gallbladder is detected during the follow-up period after RCC treatment.

Sections du résumé

BACKGROUND BACKGROUND
Metastasis of renal cell carcinoma (RCC) to the gallbladder is rare, and its clinicopathological feature remains poorly understood. We here present two cases of gallbladder metastasis from RCC presenting as a hypervascular polypoid lesion.
CASE PRESENTATION METHODS
The first case was a 73-year-old man who had undergone right nephrectomy for clear cell RCC. Imaging studies detected a hypervascular polypoid lesion in the gallbladder 6 years after nephrectomy. Laparoscopic cholecystectomy was done. The pathological findings of the polypoid lesion showed proliferation of clear cells in the submucosal layer. Immunohistochemically, the tumor was positive for carbonic anhydrase 9 (CA9) but negative for cytokeratin 7 (CK7), suggestive of metastatic RCC. The second case was a 43-year-old man who had undergone right nephrectomy for clear cell RCC. Imaging studies revealed a hypervascular polypoid lesion of 20 mm in diameter in the gallbladder 1 year after nephrectomy. The patient underwent expanded cholecystectomy and extra-hepatic bile duct resection with lymphadenectomy. Microscopically, the polypoid lesion of the gallbladder was composed of clear cells in the submucosal layer. Immunohistochemical analysis showed positive staining for epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA) but negative staining for CK7, leading to the diagnosis of metastatic RCC.
CONCLUSIONS CONCLUSIONS
Gallbladder metastasis from RCC is rare but should be considered when a hypervascular polypoid lesion in the gallbladder is detected during the follow-up period after RCC treatment.

Identifiants

pubmed: 32347406
doi: 10.1186/s40792-020-00814-z
pii: 10.1186/s40792-020-00814-z
pmc: PMC7188748
doi:

Types de publication

Journal Article

Langues

eng

Pagination

86

Références

Zhonghua Zhong Liu Za Zhi. 2015 Nov;37(11):823-6
pubmed: 26887511
J Clin Oncol. 1998 Jun;16(6):2261-6
pubmed: 9626229
J Cancer Res Clin Oncol. 1988;114(6):605-12
pubmed: 3204107
Urol Oncol. 2012 Jul-Aug;30(4):476-81
pubmed: 21277810
Biomarkers. 2017 Mar;22(2):123-126
pubmed: 27775441
Pathol Res Pract. 1995 Dec;191(12):1259-65; discussion 1266
pubmed: 8927575
Asian J Urol. 2016 Oct;3(4):286-292
pubmed: 29264197
Urol Case Rep. 2019 Jan 08;23:69-71
pubmed: 30705826
J Med Case Rep. 2018 May 31;12(1):162
pubmed: 29855393
Urology. 2013 Oct;82(4):846-51
pubmed: 24074981
Saudi J Kidney Dis Transpl. 2013 Jan;24(1):100-4
pubmed: 23354202

Auteurs

Takuya Oba (T)

Department of Surgery1, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan. t-oba@med.uoeh-u.ac.jp.

Norihiro Sato (N)

Department of Surgery1, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.

Toshihisa Tamura (T)

Department of Surgery1, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.

Katsushi Fujimoto (K)

Department of Surgery1, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.

Atsuji Matsuyama (A)

Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

Keiji Hirata (K)

Department of Surgery1, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.

Classifications MeSH